摘要
目的:了解我院调血脂药的应用情况及趋势。方法:对我院2007~2008年调血脂药的应用品种、销售金额、用药频度、限定日费用等进行统计、分析。结果:2008年度调血脂药的用药金额高于2007年,特别是阿托伐他汀和辛伐他汀等几种排名靠前的药物;两年来,用药金额和用药频度排在前2位的药品是阿托伐他汀和辛伐他汀。结论:我院各类调血脂药中他汀类药物占主导地位;但仍要增强合理使用调血脂药的意识,充分发挥药师在合理使用调血脂药的作用。
Objective: To analyze the clinical application and trend of lipid modifying agents in our hospital. Method: The application of lipid modifying agents in our hospital from 2007 to 2008 was statistically analyzed in respect of drug varieties, consumption sum, DDDs and defined daily cost,etc. Result:The sum of lipid modifying agents consumed in 2008 was more than that in 2007, especially that of several top-ranking drugs such as atorvastatin and simvastatin. Over the 2 years, the top 2 drugs were both atorvastatin and simvastatin in respect to their annual consumption sum and DDDs. Conclusion: Statins were dominant in various types of lipid modifying agents in our hospital. Still the awareness of the rational use of lipid modifying agents needs to be enhanced, and a full play should be given to pharmacists in the reasonable use of lipid modifying agents.
出处
《药物流行病学杂志》
CAS
2010年第7期409-410,413,共3页
Chinese Journal of Pharmacoepidemiology
关键词
调血脂药
销售金额
用药频度
Lipid modifying agents
Consumption sum
DDDs